反応式
[CH3:1][C@H:2]1[C@:19]([OH:24])([C:20]([CH2:22][OH:23])=[O:21])[C@:18]2([CH3:25])[C@H:4]([C@H:5]3[C@:15]([F:27])([C@@H:16]([OH:26])[CH2:17]2)[C@:14]2([CH3:28])[C:8](=[CH:9][C:10]([CH:12]=[CH:13]2)=[O:11])[CH2:7][CH2:6]3)[CH2:3]1.[C:29]1(=[O:35])[O:34][C:32](=[O:33])[CH2:31][CH2:30]1>N1C=CC=CC=1.CN(C1C=CN=CC=1)C>[CH3:1][C@H:2]1[C@:19]([OH:24])([C:20]([CH2:22][O:23][C:29]([CH2:30][CH2:31][C:32]([OH:34])=[O:33])=[O:35])=[O:21])[C@:18]2([CH3:25])[C@H:4]([C@H:5]3[C@:15]([F:27])([C@@H:16]([OH:26])[CH2:17]2)[C@:14]2([CH3:28])[C:8](=[CH:9][C:10]([CH:12]=[CH:13]2)=[O:11])[CH2:7][CH2:6]3)[CH2:3]1参加物
5
実験手順
An amount equivalent to 0.030 g of dexamethasone (1, 0.076 mmol, 1.0 equiv.) was completely dissolved in 1 mL of pyridine (non-anhydrous) and 0.038 g of succinic anhydride (0.382 mmol, 5.0 equiv.) was added to the clear solution. Then 1-2 mg of DMAP (7.6 μmol, 0.1 equiv.) was added to the solution and reaction was allowed to run for 48 h at r.t. under N2-flow. After 48 h, pyridine was evaporated under reduced pressure (in a rotary evaporator). A volume equivalent to 10 mL of H2O was added to the evaporated residue. A white precipitate was observed which was stirred for 10 minutes and then centrifuged. The resulting precipitate was washed again with 10 mL of H2O and the washed residue was lyophilized to yield the target product (2).
後処理
- waitAfter 48 h
- custompyridine was evaporated under reduced pressure (
- customin a rotary evaporator)
- additionA volume equivalent to 10 mL of H2O was added to the evaporated residue
- washThe resulting precipitate was washed again with 10 mL of H2O
出典と根拠
- ORDレコード
- ord-2a33efbe14884b429230be4adb88a565
- 出典データセット
- uspto-grants-2016_03
- 特許番号
- US09289506B2
関連ノート
読み込み中…